Burnout: The Musical; Debt Ceiling May Stymie Research; Diet’s ‘Powerful Ability’

An actor-turned-oncologist is starring in his own musical: “How to Avoid Burnout in 73 Minutes: A Minimally Invasive Procedure.”

The debt ceiling legislation under consideration “would considerably restrict potential resources for the National Institutes of Health (NIH) and National Cancer Institute (NCI) at a time when scientists are on the cusp of so many promising cancer discoveries,” according to the American Society of Clinical Oncology (ASCO).

Blue Earth Diagnostics announced FDA approval of flotufolastat F 18 (Posluma) for prostate-specific membrane antigen-targeted imaging in prostate cancer staging.

Building on the success of a previous trial, NCI announced plans for a large precision medicine study that will use a patient’s own tumor biology to select combinations of new drug therapies.

Patients with newly diagnosed cancer need help navigating the cancer system. (STAT)

A proposal under consideration to change the coding and payment rules for a certain type of breast reconstruction could limit patients’ options for the surgery. (KFF Health News)

High-risk patients who have consecutive negative CT screening scans for lung cancer may require some prodding to continue the recommended annual screens. (University of California Los Angeles, JAMA Network Open)

European cancer specialists have taken a key step toward developing international standards for use of patient-reported outcomes in cancer clinical trials. (EORTC, The Lancet Oncology)

One of the largest-ever reviews of diet and cancer showed that specifically designed diets have a “powerful ability” to prevent cancer, slow cancer growth, and help improve outcomes of cancer treatment. (Centro Nacional de Investigaciones Oncológicas, Trends in Molecular Medicine)

The ASCO annual meeting begins today in Chicago and continues through Tuesday, and MedPage Today will have complete coverage.